课题基金 / 基金详情

Exploration of new approaches to microbial typing and phenotypic characterization based on Fourier transform infrared and high-resolution magic-angle spinning NMR spectroscopy and the development of active packaging employing natural antimicrobials

Exploration of new approaches to microbial typing and phenotypic characterization based on Fourier transform infrared and high-resolution magic-angle spinning NMR spectroscopy and the development of active packaging employing natural antimicrobials
基于傅里叶变换红外和高分辨率魔角旋转核磁共振波谱探索微生物分型和表型表征的新方法以及采用天然抗菌剂的活性包装的开发
批准号:
RGPIN-2019-07277
负责人:
Ismail, Ashraf
金额:
$2.04万
依托单位:
依托单位国家:
加拿大
项目类别:
Discovery Grants Program - Individual
财政年份:
2022
资助国家:
加拿大
项目状态:
已结题
起止时间:
2022-01-01 至 2023-12-31

项目摘要

项目成果

Ismail, Ashraf的其他基金

相似基金

相关文献

中文摘要
翻译
拟议的发现补助金研究的第一个方面将致力于探索基于傅里叶变换红外(FTIR)光谱,高分辨率魔角旋转(HRMAS)NMR和质谱差异的密切相关的细菌菌株之间的区别性,重点是它们在微生物分型,爆发检测和生物标志物发现中的应用。在我们的工作中,这些能力正在被利用来开发用于鉴定耐甲氧西林金黄色葡萄球菌(MRSA)和万古霉素耐药肠球菌(VRE)等耐药性细菌的快速方法,这些细菌是医疗保健相关感染的最常见原因之一,并鉴定新兴的多药耐药临床酵母菌分离株,如耳念珠菌。这项工作是通过与加拿大卫生部、魁北克临床监测机构和魁北克各地的多家医院合作研究进行的。关于食源性疾病,正在与加拿大卫生部和加拿大食品检验局(CFIA)的研究人员合作,旨在研究致病性大肠杆菌的遗传变异性的影响。大肠杆菌致病型(与食源性疾病相关)与其毒力的关系。我们的工作首先需要从微生物中采集大量的光谱数据集,以创建包含大量FTIR,1H和31P HRMAS NMR和质谱(MS)光谱的光谱数据库,并通过应用特征选择算法结合多元统计分析技术提取歧视性光谱信息。拟议研究的一个主要目标是开发新的策略,旨在阐明特定细菌菌株之间光谱差异的具体生化差异。预计拟议研究的结果将推动生物标志物的发现,不仅在我们的微生物鉴定和分类工作中,而且在快速发展的微生物分型领域,并可能有助于开发新的抗生素,可以治疗抗生素医院感染水平的上升导致医院爆发。拟议研究的第二个方面将侧重于探索蛋白质与选定多糖的组合作为可生物降解薄膜的成分,并将天然抗菌剂嵌入薄膜中,以阻止新鲜和最低限度加工食品的微生物生长。拟议的研究重点是红外成像显微镜的应用,以研究分布,迁移率的天然抗菌剂在生物可降解薄膜,以提高其在活性包装的潜在用途。
英文摘要
The first facet of the proposed Discovery Grant research will be directed toward the exploration of the discriminatory nature between closely related bacterial strains based on differences in their Fourier transform infrared (FTIR) spectra, high-resolution magic angle spinning (HRMAS) NMR and mass spectrometry with a focus on their application to microbial typing, outbreak detection and biomarker discovery. In our work, these capabilities are being exploited to develop rapid methods for identification of antibiotic-resistant bacteria such as methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE), which are among the most prevalent causes of healthcare-associated infections, and identification of emerging multi-drug resistant clinical yeast isolates such as Candida auris. This work is being conducted through collaborative studies with Health Canada, the Quebec clinical surveillance agency and multiple hospitals across Quebec. With regards to foodborne illness, ongoing efforts, in collaboration with researchers at Health Canada and the Canadian Food Inspection Agency (CFIA), is aimed at studying the effect of genetic variability of pathogenic E. coli pathotypes (associated with foodborne illness) to its virulence by whole genome sequencing and FTIR spectroscopy. Our work initially entails acquisition of a large spectral datasets from of microorganisms for the creation of spectral databases containing large numbers of FTIR, 1H and 31P HRMAS NMR and mass spectrometry (MS) spectra of well-characterized strains and extracting the discriminatory spectral information by applying feature-selection algorithms in conjunction with multivariate statistical analysis techniques. A major objective of the proposed research is to develop new strategies directed toward elucidation of the specific biochemical differences underlying the spectral differences among particular bacterial strains. It is anticipated that the results of the proposed research will advance biomarker discovery not only in our work on microbial identification and classification but also in the rapidly evolving field of microbial typing and may aid in the development of new antibiotics that can treat the rising levels of antibiotic nosocomial infections resulting in hospital outbreaks. The second facet of the proposed research will focus on the exploration of proteins in combination of selected polysaccharides as components of biodegradable films and embedding the films with natural antimicrobials to retard microbial growth of fresh and minimally processed foods. The proposed research focuses on the application of infrared imaging microscopy to study the distribution, migration rates of natural antimicrobials in biodegradable films in relation to enhancing their potential use in active packaging.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Exploration of new approaches to microbial typing and phenotypic characterization based on Fourier transform infrared and high-resolution magic-angle spinning NMR spectroscopy and the development of active packaging employing natural antimicrobials
  • 批准号:
    RGPIN-2019-07277
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.04万
  • 财政年份:
    2021
  • 负责人:
    Ismail, Ashraf
  • 依托单位:
Exploration of new approaches to microbial typing and phenotypic characterization based on Fourier transform infrared and high-resolution magic-angle spinning NMR spectroscopy and the development of active packaging employing natural antimicrobials
  • 批准号:
    RGPIN-2019-07277
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.04万
  • 财政年份:
    2020
  • 负责人:
    Ismail, Ashraf
  • 依托单位:
Integration of Near-Infrared Spectroscopy-Based Process Analytical Technology with a Bench-Scale Continuous Manufacturing Process for an Omega-3 Phospholipid Pharmaceutical Product
  • 批准号:
    543888-2019
  • 项目类别:
    Collaborative Research and Development Grants
  • 资助金额:
    $17.14万
  • 财政年份:
    2020
  • 负责人:
    Ismail, Ashraf
  • 依托单位:
Rapid, reagent-free technology for identification of methicillin-resistant staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE) in clinical microbiology labs
  • 批准号:
    500176-2016
  • 项目类别:
    Idea to Innovation
  • 资助金额:
    $4.37万
  • 财政年份:
    2019
  • 负责人:
    Ismail, Ashraf
  • 依托单位:
国内基金
海外基金
脊髓新鉴定SNAPR神经元相关环路介导SCS电刺激抑制恶性瘙痒
  • 批准号:
    82371478
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    焦英甫
  • 依托单位:
tau轻子衰变与新物理模型唯象研究
  • 批准号:
    11005033
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    18.0万元
  • 批准年份:
    2010
  • 负责人:
    李文君
  • 依托单位:
HIV gp41的NHR区新靶点的确证及高效干预
强子对撞机上新物理信号的多轻子末态研究
  • 批准号:
    10675110
  • 项目类别:
    面上项目
  • 资助金额:
    36.0万元
  • 批准年份:
    2006
  • 负责人:
    蒋一
  • 依托单位: